Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Hair regrowth improved, but quality of life did not.

Narrowband-UVB phototherapy successfully treated a rare case of Graham Little-Piccardi-Lassueur syndrome.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

Skin Radiance Collagen improved skin and hair health in adult females.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

Inherited color dilution in rabbits is linked to DNA methylation changes.

Tandem repeats significantly influence hair color, especially darker shades, across different ancestries.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Internet and community fair recruitment effectively gathered a diverse group for a menstrual health survey.

The meeting discussed various skin conditions, treatments, and unusual cases, highlighting the effectiveness of tetracycline in treating rosacea.

Using electronic health records can help identify drug side effects but has some limitations.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

Hairless rats are good for testing anti-inflammatory drugs, similar to haired rats, without needing to remove fur.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.